Top Stories2 months ago
Nektar Therapeutics Insider Jonathan Zalevsky Sells 180 Shares
Jonathan Zalevsky, an insider at Nektar Therapeutics (NASDAQ:NKTR), sold 180 shares of the company’s stock on February 18, 2024. The shares were sold at an average...